跳至主要内容
临床试验/NCT02900196
NCT02900196终止不适用

Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders

Danone Research2 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2016年9月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
136
试验地点
2
主要终点
Occurrence of AAD

研究概览

简要总结

The purpose of this clinical study is to evaluate the effect of a four-week consumption of a fresh fermented dairy drink containing probiotic strains on Antibiotic-Associated Diarrhea and Gastro-Intestinal disorders in adult subjects treated for Helicobacter pylori eradication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who have read and signed the Study Informed Consent Form
  • Subjects positive for Helicobacter pylori infection and symptomatic due to Helicobacter pylori infection
  • Subjects with an indication, as stated by a Gastroenterologist, for the eradication of Helicobacter pylori

排除标准

  • Female subjects with a positive pregnancy test (based on serum test), or planning to become pregnant during the study or breast-feeding women
  • Subjects enrolled in another interventional clinical study in the last 4 weeks or in an exclusion period following participation in another clinical trial
  • Subject who have a history of alcohol abuse
  • Subjects having diarrhea within the preceding 4-weeks
  • Subjects with severe life-threatening illness, severe evolutive or chronic pathology
  • Immune-suppressed subjects
  • Subjects with benign peptic ulcer or pre-malignant or malignant lesion
  • Subjects presenting with an infection of the gastrointestinal tract
  • Subjects with any past severe gastro-intestinal or metabolic pathology
  • Subjects with history of Helicobacter pylori eradication therapy
  • Subjects with history of cardiac or renal clinically significant disease
  • Subjects that have had any surgery or intervention requiring general anesthesia in the last 4 weeks, or that have any planned
  • Subjects with allergy or hypersensitivity against the medication for the eradication of Helicobacter pylori
  • Subjects taking treatments likely to interfere with the evaluation of study parameters.
  • Subjects with allergy or hypersensitivity to any component of the study products

研究组 & 干预措施

1 - Test

Experimental

干预措施: 1 - Fermented dairy drink (Other)

2 - Placebo

Placebo Comparator

干预措施: 2 - Acidified dairy drink (Other)

结局指标

主要结局

Occurrence of AAD

时间窗: From Day 0 to Day 28

次要结局

  • Duration of AAD(From Day 0 to Day 28)
  • Time to event of AAD(From Day 0 to Day 28)
  • Occurrence of Clostridium difficile Associated Diarrhea(From Day 0 to Day 28)
  • Time to event of Clostridium difficile Associated Diarrhea(From Day 0 to Day 28)
  • Duration of Clostridium difficile Associated Diarrhea(From Day 0 to Day 28)
  • Number of days with main GI symptoms (diarrhea, abdominal pain, bloating, nausea, vomiting)(From Day 0 to Day 28)
  • Score of gastrointestinal symptoms(From Day 0 to Day 28)

研究者

发起方
Danone Research
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验